1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
|
|
|
- CAS号:
- 206055-67-6
- 英文名:
- 1-[2,5-Anhydro-4-C-(hydroxymethyl)-alpha-L-lyxofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione
- 英文别名:
- LNA-5MeU;LNA-methyl-U;2'-O-4'-C-Locked-T;5-Methyl-2'-O,4'-C-methyleneuridine;5-Methyl-2’-O,4’-C-methyleneuridine;5-Methyl-2’-O,4’-C-methyleneuridine, LNA-5MeU;1-(2'-O-4-C-Methylene-b-D-ribofuranosyl)thymine;1-(2'-O,4-C-Methylene-β-D-ribofuranosyl)thymine;1-(2'-O,4-C-Methylene-beta-D-ribofuranosyl)thymine;LNA-002 1-(2'-O, 4-C-Methylene-β-D- ribofuranosyl)thyMine
- 中文名:
- 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
- 中文别名:
- 2'-O-4'-C-LOCKED-T;5-甲基-2'-O,4'-C-亚甲基尿苷;1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶;1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶;1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶核苷;1-(2'-O-4-C-亚甲桥基-BETA-D-呋喃核糖基)胸腺嘧啶
- CBNumber:
- CB42128625
- 分子式:
- C11H14N2O6
- 分子量:
- 270.24
- MOL File:
- 206055-67-6.mol
|
|
|
1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶化学性质
-
熔点:
-
196-198 °C
-
|
-
密度:
-
1.598
-
|
-
储存条件:
-
Store at -20°C
-
|
-
酸度系数(pKa):
-
9.46±0.10(Predicted)
-
|
1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶性质、用途与生产工艺
1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine 是一种双环核苷。
1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2023/03/20 | HY-111638 | 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine | 206055-67-6 | 25 mg | 7800元 |
| 2023/03/20 | HY-111638 | 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine | 206055-67-6 | 50 mg | 12500元 |
1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
生产厂家
206055-67-6, 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶 相关搜索:
- Nucleosides
- 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
- 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶核苷
- 5-甲基-2'-O,4'-C-亚甲基尿苷
- 2'-O-4'-C-LOCKED-T
- 1-(2'-O-4-C-亚甲桥基-BETA-D-呋喃核糖基)胸腺嘧啶
- 1-(2'-O,4-C-甲桥-BETA-D-呋喃核糖基)胸腺嘧啶
- 206055-67-6
- 5-Methyl-2’-O,4’-C-methyleneuridine
- LNA-5MeU
- 2'-O-4'-C-Locked-T
- 2,4(1H,3H)-Pyrimidinedione, 1-[2,5-anhydro-4-C-(hydroxymethyl)-α-L-lyxofuranosyl]-5-methyl- (9CI, ACI)
- 1-(2'-O,4-C-Methylene-β-D-ribofuranosyl)thymine
- LNA-methyl-U
- 1-[(1S,3R,4R,7S)-7-Hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methylpyrimidine-2,4(1H,3H)-dione
- 5-Methyl-2’-O,4’-C-methyleneuridine, LNA-5MeU
- 2,4(1H,3H)-Pyrimidinedione, 1-[2,5-anhydro-4-C-(hydroxymethyl)-α-L-lyxofuranosyl]-5-methyl-
- 2,4(1H,3H)-PYRIMIDINEDIONE, 1-[2,5-ANHYDRO-4-C-(HYDROXYMETHYL)-ALPHA-L-LYXOFURANOSYL]-5-METHYL-
- 5-Methyl-2'-O,4'-C-methyleneuridine
- LNA-002 1-(2'-O, 4-C-Methylene-β-D- ribofuranosyl)thyMine
- 1-(2'-O-4-C-Methylene-b-D-ribofuranosyl)thymine
- 1-[2,5-Anhydro-4-C-(hydroxymethyl)-alpha-L-lyxofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione
- 1-(2'-O,4-C-Methylene-beta-D-ribofuranosyl)thymine